LifeMD Reports Q3 2021 Revenue Up 127% to Record $24.9 Million and 24% Sequential Improvement in Adjusted EBITDA

NEXT STORY
Vor Reports Third Quarter 2021 Financial Results and Provides Company Update
PREV STORY
Sight Sciences Announces FDA Authorization for the PRECISION Trial, a Groundbreaking Three-Arm Randomized, Controlled IDE Trial of Canal Viscodilation in Combination with Cataract Surgery in Adults with Primary Open-Angle Glaucoma (POAG)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

FIT Biotech Oy: Conversion of FIT Biotech Oy’s Convertible Capital Notes into shares

FIT Biotech Oy Company release January 18, 2019 at 04:00 PM EET Conversion of ...

author_avatar
NASDAQ Market News

FDA ACCEPTS FOR REVIEW NEW DRUG APPLICATION FOR SODIUM ZIRCONIUM CYCLOSILICATE (ZS-9) FOR THE TREATMENT OF HYPERKALAEMIA

18 October 2016 [07:00] AstraZeneca today announced that the US Food and Drug Administration ...

author_avatar
NASDAQ Market News

Management System for Healthcare Facilities Market 2021 End-User Demand by Types, Top Players, Regions, Service Provides, Nursing Homes & Forecast to 2027

author_avatar
NASDAQ Market News